IGWM
TGTX icon

ICA Group Wealth Management’s TG Therapeutics TGTX Stock Holding History

ICA Group Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25
Closed -$380 – 1275
2024
Q1 		$380 Buy
+25
New +$398 ﹤0.01% 1305

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ICA Group Wealth Management's TGTX Position: Q2 2024 in Review

ICA Group Wealth Management sold out of TG Therapeutics (TGTX) in Q2 2024, closing a stake of 25 shares — an estimated $380 sold.

ICA Group Wealth Management first reported a position in TGTX in Q1 2024 and held it in 1 quarter. The position peaked at $380 in Q1 2024. 259 funds tracked by Wall St. Rank hold TGTX as of Q2 2024.

  • ICA Group Wealth Management reported no remaining TG Therapeutics position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 25 TG Therapeutics shares in Q2 2024, an estimated $380.
  • ICA Group Wealth Management first reported a position in TG Therapeutics in Q1 2024 and held it in 1 quarter.
  • ICA Group Wealth Management's TG Therapeutics position peaked at $380 in Q1 2024.
  • 259 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.